Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
British Journal of Pharmacology
|
July 24, 2010
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?
W-S V Ho
European Journal of Pharmacology
|
January 24, 2013
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase
W-S V Ho
British Journal of Pharmacology
|
January 25, 2007
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol
W-S V Ho, M D Randall
Handbook of Experimental Pharmacology
|
April 7, 2006
Modulators of endocannabinoid enzymic hydrolysis and membrane transport
W S V Ho, C J Hillard
Advances in Pharmacology (San Diego, Calif.)
|
August 23, 2017
Cannabinoids in the Cardiovascular System
Wing S V Ho, Melanie E M Kelly
British Journal of Pharmacology
|
August 22, 2015
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol
W S V Ho, X Zheng, D X Zhang
British Journal of Pharmacology
|
March 4, 2017
Pro-contractile effects of perivascular fat in health and disease
J G Ramirez, E J O'Malley, W S V Ho
British Journal of Pharmacology
|
August 13, 2008
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
W-S V Ho, D A Barrett, M D Randall
Neurogastroenterology and Motility
|
August 25, 2010
Cannabinoid-induced reduction in antral pacemaker frequency: a telemetric study in the ferret
N Percie du Sert, W-S V Ho, J A Rudd, et al.
Pharmacopsychiatry
|
March 4, 2008
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report
M N Hill, G E Miller, W-S V Ho, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
British Journal of Pharmacology
|
July 24, 2010
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?
W-S V Ho
European Journal of Pharmacology
|
January 24, 2013
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase
W-S V Ho
British Journal of Pharmacology
|
January 25, 2007
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol
W-S V Ho, M D Randall
Handbook of Experimental Pharmacology
|
April 7, 2006
Modulators of endocannabinoid enzymic hydrolysis and membrane transport
W S V Ho, C J Hillard
Advances in Pharmacology (San Diego, Calif.)
|
August 23, 2017
Cannabinoids in the Cardiovascular System
Wing S V Ho, Melanie E M Kelly
British Journal of Pharmacology
|
August 22, 2015
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol
W S V Ho, X Zheng, D X Zhang
British Journal of Pharmacology
|
March 4, 2017
Pro-contractile effects of perivascular fat in health and disease
J G Ramirez, E J O'Malley, W S V Ho
British Journal of Pharmacology
|
August 13, 2008
'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
W-S V Ho, D A Barrett, M D Randall
Neurogastroenterology and Motility
|
August 25, 2010
Cannabinoid-induced reduction in antral pacemaker frequency: a telemetric study in the ferret
N Percie du Sert, W-S V Ho, J A Rudd, et al.
Pharmacopsychiatry
|
March 4, 2008
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report
M N Hill, G E Miller, W-S V Ho, et al.
Page
of 2